Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
Patrick Byanyima, Sylvia Kaswabuli, Emmanuel Musisi, Catherine Nabakiibi, Josephine Zawedde, Ingvar Sanyu, Abdul Sessolo, Alfred Andama, William Worodria, Laurence Huang, View ORCID ProfileJ. Lucian Davis
doi: https://doi.org/10.1101/2022.03.16.22272031
Patrick Byanyima
1Infectious Diseases Research Collaboration, Kampala, Uganda
Sylvia Kaswabuli
1Infectious Diseases Research Collaboration, Kampala, Uganda
Emmanuel Musisi
2Division of Infection and Global Health, School of Medicine, University of St. Andrews, UK
Catherine Nabakiibi
1Infectious Diseases Research Collaboration, Kampala, Uganda
Josephine Zawedde
1Infectious Diseases Research Collaboration, Kampala, Uganda
Ingvar Sanyu
1Infectious Diseases Research Collaboration, Kampala, Uganda
Abdul Sessolo
1Infectious Diseases Research Collaboration, Kampala, Uganda
Alfred Andama
1Infectious Diseases Research Collaboration, Kampala, Uganda
5Department of Internal Medicine, Makerere University College of Health Sciences, Uganda
William Worodria
1Infectious Diseases Research Collaboration, Kampala, Uganda
5Department of Internal Medicine, Makerere University College of Health Sciences, Uganda
Laurence Huang
3Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, California, USA
4Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA
J. Lucian Davis
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA
7Pulmonary, Critical Care, and Sleep Medicine Section, Yale School of Medicine, New Haven, Connecticut, USA
Data Availability
A comprehensive, de-identified dataset containing individual-level data will be made available prior to publication online at the Dryad website.
Posted March 18, 2022.
Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
Patrick Byanyima, Sylvia Kaswabuli, Emmanuel Musisi, Catherine Nabakiibi, Josephine Zawedde, Ingvar Sanyu, Abdul Sessolo, Alfred Andama, William Worodria, Laurence Huang, J. Lucian Davis
medRxiv 2022.03.16.22272031; doi: https://doi.org/10.1101/2022.03.16.22272031
Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
Patrick Byanyima, Sylvia Kaswabuli, Emmanuel Musisi, Catherine Nabakiibi, Josephine Zawedde, Ingvar Sanyu, Abdul Sessolo, Alfred Andama, William Worodria, Laurence Huang, J. Lucian Davis
medRxiv 2022.03.16.22272031; doi: https://doi.org/10.1101/2022.03.16.22272031
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2772)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12423)
- Forensic Medicine (10)
- Gastroenterology (786)
- Genetic and Genomic Medicine (4289)
- Geriatric Medicine (396)
- Health Economics (703)
- Health Informatics (2770)
- Health Policy (1025)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4066)
- Nursing (218)
- Nutrition (602)
- Oncology (2145)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (78)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6671)
- Radiology and Imaging (1457)
- Respiratory Medicine (888)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (171)